Liventa Bioscience

About:

AFCell Medical develops cellular and biologic products for patients and physicians.

Website: http://www.liventabioscience.com

Description:

Liventa is the trusted innovator in living donor tissues that advance regenerative medicine for wound care and surgical interventions. These technologies enhance medicine by accelerating healing and reducing complications in a cost-effective manner. Liventa’s lead technology platform is AmnioClear™, a natural tissue covering designed for difficult-to-heal wounds or as a biologically active barrier in critical surgical anatomy. AmnioClear is a combination of amnion and chorion—two layers of the placenta—that work with the body’s regenerative processes to help balance healing, regulate inflammation, minimize microbial colonization and restore natural tissue functionality.

Total Funding Amount:

$2.63M

Headquarters Location:

Conshohocken, Pennsylvania, United States

Founded Date:

2006-01-01

Contact Email:

dbuche(AT)LiventaBio.com

Founders:

Robin Young

Number of Employees:

1-10

Last Funding Date:

2014-10-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai